BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rangel-Sosa MM, Aguilar-Córdova E, Rojas-Martínez A. Immunotherapy and gene therapy as novel treatments for cancer. Colomb Med (Cali) 2017;48:138-47. [PMID: 29213157 DOI: 10.25100/cm.v48i3.2997] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Zang W, Mi Z, Li J, Wang L, Xie D, Zhao L, Wang D. Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy. Journal of Controlled Release 2022;352:256-275. [DOI: 10.1016/j.jconrel.2022.10.022] [Reference Citation Analysis]
2 Marcovici I, Coricovac D, Pinzaru I, Macasoi IG, Popescu R, Chioibas R, Zupko I, Dehelean CA. Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research-A Review. Cancers (Basel) 2022;14:1838. [PMID: 35406610 DOI: 10.3390/cancers14071838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Dituri F, Mancarella S, Serino G, Chaoul N, Lupo LG, Villa E, Fabregat I, Giannelli G. Direct and Indirect Effect of TGFβ on Treg Transendothelial Recruitment in HCC Tissue Microenvironment. Int J Mol Sci 2021;22:11765. [PMID: 34769191 DOI: 10.3390/ijms222111765] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kumar AR, Devan AR, Nair B, Vinod BS, Nath LR. Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets. Mol Biol Rep 2021;48:8075-95. [PMID: 34671902 DOI: 10.1007/s11033-021-06752-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
5 Zhang C, Peng L, Ji J, Jiao W. [Research Progress of Circular RNAs in Tumor Immunotherapy]. Zhongguo Fei Ai Za Zhi 2021;24:698-704. [PMID: 34628781 DOI: 10.3779/j.issn.1009-3419.2021.101.31] [Reference Citation Analysis]
6 Alekseenko I, Kuzmich A, Kondratyeva L, Kondratieva S, Pleshkan V, Sverdlov E. Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement. Int J Mol Sci 2021;22:9376. [PMID: 34502287 DOI: 10.3390/ijms22179376] [Reference Citation Analysis]
7 Rosik J, Szostak B, Machaj F, Pawlik A. The Role of CTLA4 and Its Polymorphisms in Solid Organ and Haematopoietic Stem Cell Transplantation. Int J Mol Sci 2021;22:3081. [PMID: 33802937 DOI: 10.3390/ijms22063081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Boyero L, Sánchez-Gastaldo A, Alonso M, Noguera-Uclés JF, Molina-Pinelo S, Bernabé-Caro R. Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy. Cancers (Basel) 2020;12:E3729. [PMID: 33322522 DOI: 10.3390/cancers12123729] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
9 Bhattarai S, Saini G, Gogineni K, Aneja R. Quadruple-negative breast cancer: novel implications for a new disease. Breast Cancer Res 2020;22:127. [PMID: 33213491 DOI: 10.1186/s13058-020-01369-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 Hager S, Fittler FJ, Wagner E, Bros M. Nucleic Acid-Based Approaches for Tumor Therapy. Cells 2020;9:E2061. [PMID: 32917034 DOI: 10.3390/cells9092061] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
11 Lei S, Zhang X, Men K, Gao Y, Yang X, Wu S, Duan X, Wei Y, Tong R. Efficient Colorectal Cancer Gene Therapy with IL-15 mRNA Nanoformulation. Mol Pharm 2020;17:3378-91. [PMID: 32787272 DOI: 10.1021/acs.molpharmaceut.0c00451] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
12 Gao SS, Wang YJ, Zhang GX, Zhang WT. Potential diagnostic value of miRNAs in peripheral blood for osteosarcoma: A meta-analysis. J Bone Oncol 2020;23:100307. [PMID: 32742918 DOI: 10.1016/j.jbo.2020.100307] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
13 Hu W, Huang F, Ning L, Hao J, Wan J, Hao S. Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory molecules. Cell Oncol (Dordr) 2020;43:889-900. [PMID: 32578140 DOI: 10.1007/s13402-020-00535-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
14 Eremina NV, Kazey VI, Mishugin SV, Leonenkov RV, Pushkar DY, Mett VL, Gudkov AV. First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients. Oncotarget 2020;11:1273-88. [PMID: 32292576 DOI: 10.18632/oncotarget.27549] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 López Perez JI, Serna Maldonado RD, Bermeo Varon LA, Castillo García JF. Estimation of Electrical Conductivity from Radiofrequency Hyperthermia Therapy for Cancer Treatment by Levenberg Marquardt Method. Communications in Computer and Information Science 2020. [DOI: 10.1007/978-3-030-42531-9_12] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Türkoğlu M, Kahveci K. İmmün Kontrol Noktası İnhibitörleri Ctla-4 ve Pd-1/Pd-l1’in İmmünoterapideki Yeri. Mehmet Akif Ersoy Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2019. [DOI: 10.29048/makufebed.569375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Li J, Zhang XH, Bei SH, Feng L. PD-1/PD-L1 antagonists in gastric cancer: Current studies and perspectives. World J Meta-Anal 2019; 7(3): 101-109 [DOI: 10.13105/wjma.v7.i3.101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]